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ABSTRACT
Objective: To explore barriers to early presentation
and diagnosis with breast cancer among black women.
Design: Systematic review.
Methods: We searched multiple bibliographic
databases (January 1991–February 2013) for primary
research, published in English, conducted in
developed countries and investigating barriers to
early presentation and diagnosis with symptomatic
breast cancer among black women (≥18 years).
Studies were excluded if they did not report separate
findings by ethnic group or gender, only reported
differences in time to presentation/diagnosis, or
reported on interventions and barriers to cancer
screening. We followed Cochrane and PRISMA
guidance to identify relevant research. Findings were
integrated through thematic synthesis. Designs of
quantitative studies made meta-analysis impossible.
Results: We identified 18 studies (6183
participants). Delay was multifactorial, individual and
complex. Factors contributing to delay included: poor
symptom and risk factor knowledge; fear of detecting
breast abnormality; fear of cancer treatments; fear of
partner abandonment; embarrassment disclosing
symptoms to healthcare professionals; taboo and
stigmatism. Presentation appears quicker following
disclosure. Influence of fatalism and religiosity on
delay is unclear from evidence in these studies. We
compared older studies (≥10 years) with newer ones
(<10 years) to determine changes over time. In older
studies, delaying factors included: inaccessibility of
healthcare services; competing priorities and
concerns about partner abandonment. Partner
abandonment was studied in older studies but not in
newer ones. Comparisons of healthy women and
cancer populations revealed differences between how
people perceive they would behave, and actually
behave, on finding breast abnormality.
Conclusions: Strategies to improve early
presentation and diagnosis with breast cancer among
black women need to address symptom recognition
and interpretation of risk, as well as fears of the
consequences of cancer. The review is limited by the
paucity of studies conducted outside the USA and
limited detail reported by published studies
preventing comparison between ethnic groups.
BACKGROUND
Breast cancer is the most common cancer
among women and leading cause of death
worldwide1 although incidence and survival
rates vary across ethnic group. Data from the
USA determined that African-American
women have a 6% lower incidence rate of
cancer but a 16% higher death rate than
white women. Further, they are less likely
Strengths and limitations of this study
▪ Several of the themes were present in a large
number of studies, indicating the strength of the
review’s findings. Findings from quantitative and
qualitative studies were broadly similar, providing
further corroborative evidence of this.
▪ However, there were some conflicting findings.
These were potentially due to differences in
when research was published and whether
studies included women who had been diag-
nosed with cancer or general populations.
▪ Most studies were conducted in the USA, which
made it difficult to draw conclusions and assess
implications for women across other developed
countries due to the particular cultural history of
the US population and the way that US health-
care is funded.
▪ Further, studies varied in their definition of, and
groupings of, ethnicities. This meant we were
unable to explore differences between black
ethnic groups.
▪ Studies also varied in their methodological
quality; small samples, limited information on
data analysis and on demographic characteristics
were common.
▪ US studies which reported on the health insur-
ance coverage of participants showed that the
majority (between 58% and 92%) were insured.
Inclusion of relatively affluent samples in some
studies may not reflect the general US black
female population. The influence of age on
women’s perceptions and delay was also not
explored systematically in any of the studies.
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than white women to present with localised breast
cancer2 Analysis of UK cancer registry data has also
shown that despite lower breast cancer incidence rates
in the UK among black African and black Caribbean
than white women, black women are more likely to be
diagnosed with metastatic disease and have poorer sur-
vival than white British women.3 This may reﬂect the
higher proportion of black women than white women
developing triple negative breast cancer—an aggressive
form of the disease associated with poorer outcomes.4 5
A second factor contributing to this disparity in the UK
and the USA relates to differing access to, and uptake
of, breast cancer screening. In both nations, screening
uptake is lower in black than in white populations and
communities.6 There is also evidence—largely from the
USA—of black and African-American women delaying
longer with symptomatic breast cancer before seeking
health professional’s help than white women. ‘Fatalism’,
fear, embarrassment, lack of trust in health services,
lower education and limited knowledge about cancer
and its symptoms have been cited as barriers to early
presentation with breast cancer in black and
African-American women.7–10 Provider delays, such as
delayed general practitioner referral to hospital diagnos-
tic services, can also contribute to late diagnosis.
The disparity in cancer outcomes between black and
white women in the USA and the UK provided the
impetus for appraising and synthesising research explor-
ing barriers to early presentation and diagnosis with
breast cancer in black women in this review. A search of
previous literature reviews on the Cochrane Database of
Systematic Reviews and other electronic databases did not
identify any reviews relevant to the one undertaken.
AIM OF THE REVIEW
This review aimed to understand barriers to early pres-
entation with, and diagnosis of, ‘symptomatic’ breast
cancer among women of black African and black
Caribbean descent living in developed countries. In the
UK, there is a national breast screening programme. All
women aged 50–70 years are invited for breast screening
every 3 years. However, separate to this, women present
symptomatically to their doctor when they discover a
breast change. It is this ‘symptomatic’ presentation
which is the focus of this review. The review includes
research carried out in developed countries only as
delays in presentation and diagnosis with cancer in
developing countries are likely to be more inﬂuenced by
the availability and accessibility of diagnostic services.
The review was undertaken to inform a qualitative study
exploring issues around symptomatic presentation with
breast cancer among black African, black Caribbean and
white British women in the UK.
METHODS
The review methodology was informed by the Cochrane
Handbook for Systematic Reviews of Interventions.11 The
following electronic databases were searched on the 27
February 2013 to identify relevant studies: MEDLINE,
PsycINFO, The Cumulative Index to Nursing and Allied
Health Literature (CINAHL) and SCOPUS. Searches
were restricted to research published from 1991 to 2013
and to English-language publications published in peer-
reviewed journals. A detailed search strategy (table 1)
was used to identify relevant papers in MEDLINE.
Similar search strategies were applied in CINAHL,
PsycInfo and SCOPUS.
Criteria for including studies in this review
Papers included in the review reported on studies con-
ducted with female adults (≥18 years) who were black,
African-American, Caribbean or African.
Inclusion criteria
To be included in the review, papers had to be:
▸ Published in English language peer-reviewed journals
in the past 20 years.
▸ Primary research articles.
▸ Studies that explored barriers to early presentation
and diagnosis with symptomatic breast cancer in
black women of 18 years or over of African or
Caribbean descent
– Including studies that explored factors affecting
women’s return for follow-up following abnormal
test results;
– Including studies that explored diagnostic delays
due to service-related factors after suspicious ﬁnd-
ings by health professionals;
– Including studies that explored attitudes to, and
undertaking of, self-examination (relating to breast
cancer);
– Including healthy women and those who had
cancer.
▸ Conducted in developed countries.
Exclusion criteria
Papers were excluded from the review if they:
▸ Did not report separate ﬁndings by ethnic group;
▸ Did not report separate ﬁndings for men and
women;
▸ Did not report separate ﬁndings for breast cancer;
▸ Only reported research carried out in developing
countries;
▸ Only reported differences in time to presentation/
diagnosis by ethnic group but did not explore factors
accounting for these differences;
▸ Only reported uptake of, or barriers to, cancer
screening;
▸ Only described interventions to increase uptake of
cancer screening and/or improve early presentation/
detection rates;
▸ Only described black women’s perceptions of cancer
without discussing how their perceptions related to/
inﬂuenced early presentation and diagnosis.
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Data collection and analysis
Titles and abstracts of all studies identiﬁed by the
searches were retrieved and reviewed by CELJ who
excluded all irrelevant papers (see online supplemen-
tary appendix 1). Abstracts from approximately 10% of
all retrieved papers, randomly sampled (n=80), were
independently reviewed by ER. Studies not excluded at
this point were retrieved in full text and assessed for
eligibility by CELJ. Excluded articles were reviewed inde-
pendently by ER or JM to ensure that studies were not
erroneously excluded.
Data extraction and quality appraisal
Data were extracted systematically from eligible papers
using Data Extraction Forms (DEFs) developed by the
team (see online supplementary appendices 2 and 3). Data
were extracted from eligible papers independently by two
from the team of reviewers (CELJ, JM, RHJ, LJLF and GL).
Methodological quality was appraised using six attri-
butes of research design that impact directly on the ver-
acity of research ﬁndings irrespective of the particular
research design (based on refs. 12–14):
1. Appropriateness of study design;
2. Suitability of data collection strategy;
3. Appropriateness of sample and sampling method;
4. Appropriateness of analytic approach/tools;
5. Level of control over confounding variables (quanti-
tative studies) or level to which research context was
adequately considered (qualitative studies);
6. Whether interpretation of ﬁndings was justiﬁed by
the data.
No papers were excluded based on quality, but lower
quality studies were given less weight in the discussion.
Data synthesis
Thematic synthesis was used to integrate ﬁndings from
qualitative and quantitative studies.15 This entailed
line-by-line coding of text from the qualitative studies.
Codes were compared to identify recurrent concepts and
patterns between themes which were subsequently orga-
nised into a framework of descriptive themes. Findings
from the quantitative studies were summarised descrip-
tively (as the design of the quantitative studies rendered it
impossible to undertake meta-analysis) and integrated into
the thematic framework. We developed new interpretative
constructs (we compared studies that were <10 years old
with studies conducted ≥10 years ago and studies of
women with and without breast cancer to explain our
Table 1 Example of search strategy (MEDLINE)
Concept 1 Concept 2 Concept 3 Concept 4
Neoplasms (SH)
neoplasm* (free
text)
cancer* (free text)
tumor* (free text)
African Continental Ancestry Group
(SH)
West Indian* (free text)
‘Afro Caribbean*’ (free text)
‘Afro American*’
African American* (free text)
African Caribbean* (free text)
Black* not (Blackwell) (free text),
minority group* (free text)
ethnic minorit* (free text)
‘Black Minority Ethnic’ (free text)
‘BME’ (free text)
Perception (SH)
Social Perception (SH)
perception* (free text)
social perception* (free
text)
opinion* (free text)
Attitude to Health (SH)
attitude* (free text)
social value* (free text)
social norm* (free text)
Culture (SH)
belief* (free text)
understanding* (free text)
language* (free text)
communicat* (free text)
fear* (free text)
mistrust (free text)
trust (free text)
cultur* (free text)
relig* (free text)
knowledge* (free text)
barrier* (free text)
embarrass* (free text)
fatalism (free text)
fatalistic (free text)
income (free text)
socioeconomic* (free text)
depriv* (free text)
educat* (free text)
poor* (free text)
poverty (free text)
Early Diagnosis (SH)
Early Detection of Cancer
(SH)
‘Late presentation’ (free text)
‘Early presentation’ (free text)
‘Early diagnos*’ (free text)
‘Late diagnos*’ (free text)
‘early detection cancer’
delay* (free text)
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ﬁndings) in order to go beyond the primary studies and to
generate new explanations and hypotheses.
RESULTS
We identiﬁed 18 papers that met our inclusion criteria
(ﬁgure 1) providing data for 6183 individuals who were
between 19 and 99 years; of these, 17 studies were con-
ducted in the USA and 1 in the UK. As most studies were
conducted in the USA, explicit reference will be made
when referring to the UK study. Eleven papers were quan-
titative, six qualitative and one with mixed methods.
Studies included women who had been diagnosed
with cancer (8), general population samples (7) and
women with abnormal mammogram or clinical breast
examinations (1). One study included both women who
had been diagnosed with breast cancer and a general
control group. In one study, it was unclear whether or
not the sample had been diagnosed with cancer.
Five quantitative studies were considered as high
quality,16–20 four were deemed to be of medium
quality21–24 and two of low quality.25 26 All six qualitative
studies were considered as medium quality.27–32 The
mixed-methods study was considered as medium
quality33 (table 2).
Ethnic deﬁnitions in the ﬁndings and discussion are
taken from the papers included in the review.
Knowledge
Low awareness of cancer symptoms and/or personal risk
A consistent ﬁnding across studies was the low level of
knowledge among black and African-American women
about symptoms of breast cancer and/or risk factors for
developing the disease.19 20 23 27–30 32 Poor knowledge of
symptoms and risk factors was associated with delay in
presentation among black and African-American women
with breast cancer.28 29 31
Poor symptom awareness and knowledge of risk factors/
personal risk
Comparisons of risk perceptions among African-
American and white women with breast cancer in two
studies revealed a signiﬁcantly lower percentage of
African-American women (25%) than white American
women (44%) felt susceptible to the disease before they
were diagnosed23 and that African-American women
were less likely than white women to believe that if a
woman has cancer it increases the risk for their daugh-
ter.20 In the UK, few black (13%) and white women
(12%) without breast cancer knew that women over
70 years are at higher risk of breast cancer than women
of any age.19
Further, a number of US studies suggested that black
and African-American women were unaware of risk
factors for breast cancer and of their personal risk of
developing it.27 29 30 32 Some women believed that
breast cancer was a ‘white woman’s disease’ and others
that they were not at risk because they did not have a
family history of breast cancer. Two studies reported that
these perceptions were reinforced by media messages
which focused on white women.27 32 Underestimation of
risk appeared to inﬂuence delayed presentation.29
Women who thought their chance of getting cancer was
low, in some cases, lacked the motivation or inclination
to check their breasts.27 29
Recognising significance of cancer symptoms
There was strong evidence to suggest that in the USA,
black and African-American women lacked knowledge of,
Figure 1 Data search and
retrieval.
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Table 2 Summary information on selected papers (AA=African-American; online supplementary appendix 4 for results of individual studies)
Reference
Site of
cancer Country Type of study Sampling method Methods N Participants Quality
16 Breast USA Quantitative Cross-sectional, purposive Face-to-face interview 184 Black women with
abnormal mammogram or
clinical breast examination
High
17 Breast USA Quantitative Cross-sectional, case-control Face-to-face interview 576 AA women General
population sample
High
18 Breast USA Quantitative Cross-sectional, convenience Self-report questionnaire,
administered in person by
investigator
129 AA women with breast
cancer
High
19 Breast UK Quantitative Cross-sectional, population-representative
sample plus booster sample for non-white
ethnic groups/women >55 years
Face-to-face, computer
assisted interview
1515 Black (n=265), white
(n=806), and South Asian
(n=333) women
General population
sample
High
20 Breast USA Quantitative Cross-sectional, convenience and
case-control
Face-to-face interview 954 AA (n=378), white (n=162)
women with breast cancer
and community controls
(n=414)
High
21 Breast USA Quantitative Cross-sectional, 70% random sample of
black women. Comparison white sample
matched by age groups
Face-to-face interview 367 Black (n=206) and white
(n=161) women with
breast cancer
Medium
22 Breast USA Quantitative Cross-sectional, convenience Self-report questionnaire,
administered in person by
investigator
352 Black and AA women
(breakdown by ethnic
group not provided)
General population
sample
Medium
23 Breast USA Quantitative Cross-sectional, convenience Self-report questionnaire,
administered by post
349 AA (n=152) and white
(n=197) women
General population
sample
Medium
24 Breast USA Quantitative Cross-sectional, convenience Self-report questionnaire
administered in person by
investigator
699 Black, white and Latino
women (breakdown by
ethnic group not provided)
General population
sample
Medium
25 Breast USA Quantitative Cross-sectional, random-stratified Face-to-face structured
interview
682 AA (n=280), white (n=402)
General population
sample
Low
26 Breast USA Quantitative Cross-sectional, convenience Self-report questionnaire,
administered in person by
investigator
60 AA women with breast
cancer
Low
Continued
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Table 2 Continued
Reference
Site of
cancer Country Type of study Sampling method Methods N Participants Quality
27 Breast USA Qualitative Convenience Focus groups, thematic
and pattern analysis
32 AA women
General population
sample
Medium
28 Breast USA Qualitative Convenience sample Focus groups, narrative
analysis
80 Black (mainly AA) (n=26),
white (n=23), Latino
(n=31) women with breast
cancer
Medium
29 Breast USA Qualitative Convenience and snowball Interviews, narrative and
content analysis
20 Black women with breast
cancer
Medium
30 Breast USA Qualitative Not provided Focus groups, thematic
and pattern analysis
100 AA women
Not stated whether they
had breast cancer or not
Medium
31 Breast USA Qualitative Purposive Ethnographic interviews,
observations, fieldnotes,
photographs, ethnographic
analysis
13 AA women with breast
cancer
Medium
32 Breast USA Qualitative Convenience Interviews, narrative and
thematic analysis
23 AA women with breast
cancer
Medium
33 Breast USA Mixed-methods Mixed- method (cross-sectional survey
with subsequent interviews
Self-report questionnaire,
administered by post
Follow-up telephone
interview
48 AA women with breast
cancer
Medium
6
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and information about, symptoms of breast cancer.27–29 32
In the UK, black women (16%) were less likely to recognise
ﬁve or more non-lump symptoms of breast cancer than
white women (22%).19 Many of those with cancer had
underestimated the signiﬁcance of their symptoms which
contributed to them a delay in presentation. For some
African-American women, there was confusion over
whether or not pain was a symptom of breast cancer.
Presence of pain reassured some African-American women
that their breast symptom was not cancer.28 32 One had
‘read that pain [was] not a risk factor’.32 Further, some
studies suggested a tendency among African-American
women to tolerate or ignore symptoms, until they were
severe, before seeking medical attention31 33:
At ﬁrst, I tried to ignore my pain but it continued to get
worse.33
In one study, some African-American women with
breast cancer only presented when their symptoms wor-
sened or they developed additional symptoms.31
Another study suggested that African-American women
were more likely than white women to delay presenta-
tion if their lump was not bothering them.20 Other con-
tributing factors to delay included women who assessed
that their symptoms were caused by stress29 or women
who had previous diagnoses of a benign breast lump.31
Empowerment and confidence
Making time to check for and/or present with symptoms
One US study identiﬁed that women who were unaware
of breast cancer symptoms lacked conﬁdence to check
their breasts.27 In the UK general population study,
breast checking differed by ethnic group; black women
were less likely than white women to report breast check-
ing (after controlling for age and socioeconomic
status).19 However, similarly high percentages of black
(50%) and white (55%) women were fairly or very conﬁ-
dent that they would notice a breast change.19
The same UK study found that barriers to symptom-
atic presentation were not more common in black than
in white women. Moreover, black women (32%) were
slightly less likely than white women (37%) to report
having too many other things to worry about, and
similar proportions reported being too busy to make
time to see the doctor (34% black, 35% white).19
Evidence from the USA also suggested that women
with family commitments would still ﬁnd time to visit
the doctor. In one study, African-American women with
cancer said that they presented despite family caring
obligations.31
Studies conducted over 10 years ago found some evi-
dence that responsibilities might lead to delayed presen-
tation: some African-American women and one black
woman reported lacking time27 29 to check their breasts.
Some black and African-American women without
breast cancer, but with childcare, employment and part-
nership responsibilities reported they would be less
likely than those without these responsibilities to seek
help for breast symptoms should they arise.22
Lack of partner support
Among black and African-American women, with and
without breast cancer, lack of partner support and con-
cerns around partner abandonment were raised when
discussing the physical effects of breast surgery on their
relationships. However, the speciﬁc inﬂuence of partner
support/abandonment on delay was unclear.20 28 30 31
In one study, black and African-American women with
breast cancer reported that fear of partner abandon-
ment inhibited help-seeking. However, this also
appeared the case for white women.28 In another study,
help-seeking was not affected, despite one woman’s
partner saying he did not want to live with, ‘no one titty
bitch’ and others saying they were concerned that they
would be less appealing to their partners.31 Limited evi-
dence indicates that African-American women are more
likely than white women to delay seeking help due to
lack of partner support.20
Stigma, taboo and fear
Stigma and taboo emerged as salient themes among
black women in the USA and the UK. They were reluc-
tant to talk about cancer, and reported that in their
communities, the word ‘cancer’ was whispered32 and
referred to as ‘the big C’.28 Cancer diagnoses often
remained undisclosed even to family members.30
However, in a US study, disclosure to others (particularly
family or friends) was associated with shorter delays in
presentation in African-American women.18 Whether
disclosure inﬂuenced decisions to seek care or reﬂected
openness to discuss cancer symptoms with others
(including healthcare professionals) was less clear. A
further study found two-thirds of African-American parti-
cipants felt they made their own decision to seek help.33
Black and African-American women who were fearful of
cancer were signiﬁcantly more likely to delay presenta-
tion than those who were not.16 31 In one study, some
African-American women were too scared to check their
breasts,27 while in another study, 32% of African-
American participants with breast cancer reported
feeling scared when they discovered their symptoms.33
However, this and another study found no relationship
between fear and delay.26 33
Religiosity
There was limited evidence to suggest that religiosity
impacted time to presentation with cancer in symptom-
atic black and African-American women. Two studies
exploring the inﬂuence of religiosity found it did not
inhibit help-seeking in women with symptomatic breast
cancer.18 28 However, there was some evidence that age31
and African-American ethnic group20 25 may predict a
belief that religious intervention inﬂuences the outcome
of cancer rather than medical treatment, as well as a
resigned acceptance of death. The link between what
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has been termed ‘fatalism’—a belief that cancer is preor-
dained—and delayed presentation is unconﬁrmed. One
study of healthy women suggested that fatalism nega-
tively inﬂuenced help-seeking intention,22 but a study of
women with breast cancer found no association between
fatalism and actual delay in presentation.18
Trust in healthcare system
Curability of cancer
There was strong evidence to suggest that black and
African-American women with and without cancer
believed that cancer could be cured.17 18 22 23 Across
three studies, 77–98% of African-American women did
not believe that death was an inevitable outcome of
cancer.17 18 23 In another study, only a small percentage
of African-American (13%) and white women (16%)
believed that cancer inevitably led to death.23 However,
another study of African-American women reported that
they believed cancer was a deadly and incurable disease
and very few of those interviewed knew of women who
had survived the disease.30 However, the inﬂuence of
that belief (cancer equates with death) on help-seeking
intention was not discussed.30
Fear of conventional treatment
Black and African-American women reported fearing
the implications of cancer treatments and
surgery17 20 28 31 and some said that they preferred non-
conventional therapies.20 Treatment fear prolonged
delay among some women with cancer. One study
reported that 57% of African-American women with and
without breast cancer believed treatments for breast
cancer were worse than the disease itself,17 while three
studies reported reluctance among African-American
women to have surgery.20 28 31 Some African-American
women reported fearing unpleasant side effects and
were worried about what treatments comprised. One
study reported that African-American women were more
likely than white women to prefer non-conventional
treatments in place of surgery.20
Quality of relationships with healthcare professionals
Concerns about interactions with doctors
In the UK study, concerns about wasting the doctor’s
time or ﬁnding it difﬁcult to talk to a doctor were bar-
riers to early presentation. However, these issues were
just as likely to be reported by white women as black
women.19
Lack of confidence in healthcare professionals
There was strong evidence suggesting black and
African-American women lacked conﬁdence in medical
professionals due to breast symptoms being previously
misdiagnosed. They expressed concerns over standards
of care and the type of care they would receive; they
were concerned about discrimination in medical set-
tings. In one study, three African-American women with
cancer were initially told their symptoms were benign
and this contributed to delayed diagnosis. For example,
one was told, “It’s just cysts, it’s nothing to worry
about.”31 Further, some black and African-American
women with cancer were concerned about doctors pro-
viding substandard, aggressive (‘she wound up with a
mastectomy 2 weeks later just because of her mammo-
gram’)28 or experimental care.28 29 The Tuskegee syph-
ilis study34 was cited by black and African-American
study participants in support of this belief.28 29 However,
one study reported that African-American women felt
that healthcare professionals should conduct breast
examinations rather than women themselves, which sug-
gested trust in the skills of healthcare professionals.27
Five studies examined black and African-American
women’s perceptions of discrimination in medical set-
tings.16 22 24 28 29 Of these, two studies determined that
although women perceived a degree of racism and dis-
crimination, this did not appear to inﬂuence delay or
help-seeking intent,16 22 but in another two studies it did
inﬂuence help-seeking intention and delay.24 28
Practical and service barriers
Financial burden of healthcare and influence of health
insurance on patient and provider delays
The impact of the ﬁnancial burden of healthcare
(affordability of healthcare and health insurance cover-
age) on delay was unclear based on the limited evidence
provided by these studies. In one study, there was no stat-
istically signiﬁcant association between perceived afford-
ability of healthcare and delay.33 In another study,
women with health insurance were not signiﬁcantly
more likely to be diagnosed within 90 days than those
without insurance.16
There was also a mixed picture of the inﬂuence of
black and African-American women’s socioeconomic
status on delay within these studies. In two of them,
socioeconomic status did not appear to inﬂuence delay
among black women with cancer.16 26 However, three
studies reported that less afﬂuent black and
African-American women were less likely to seek help
for cancer symptoms and this did contribute to delayed
presentation.18 20 22
Perceptions of access to healthcare services
In the UK study, access issues such as ease of booking
appointments, arranging transport and distance between
home and health centres appeared no more common in
black women than white women. Rather, black women
were less likely than white women to report difﬁculties
making an appointment as a barrier to help-seeking
(black 30%, white 36%). Difﬁculties in arranging trans-
port were again less of a barrier (black 14%, white 16%)
in black women. Overall, transport appeared a less
common barrier than challenges with making appoint-
ments to see their doctor.19
In the US studies, the effect of access issues on delay
was mixed. In a study of black and African-American
women without breast cancer, being more likely to
8 Jones CEL, Maben J, Jack RH, et al. BMJ Open 2014;4:e004076. doi:10.1136/bmjopen-2013-004076
Open Access
intend to seek help was signiﬁcantly linked to positive
perceptions of accessibility to healthcare.28 Further, in
another study, poorer access to healthcare among black
women with breast cancer made attending appointments
difﬁcult.21 However, two studies reported little evidence
indicating access issues impacted on delay among black
and African-American women with cancer.16 33
FACTORS WHICH MAY EXPLAIN THE REVIEW FINDINGS
It was evident that some barriers to early presentation
with cancer were more prevalent 10 years ago than the
current scenario and vice versa. Accessibility of health-
care services21 22 and competing priorities22 27 29 were
important issues inﬂuencing delay in black and African-
American women in older (≥10 years) studies. However,
in some recent studies (≤10 years), access to health-
care16 19 33 and competing priorities19 31 were reported
to neither inﬂuence delay nor help-seeking intention.
Although the inﬂuence of partner abandonment was
examined in one early quantitative study20 and emerged
from women’s narratives in three early qualitative
studies,28 30 31 this theme was not examined in any
recent quantitative studies. This does not mean,
however, that it is not a current problem, only that it has
not been examined as a potential inﬂuence over time.
Several differences were also noted between women
with and without cancer. Competing priorities did not
inﬂuence delay in a recent study of women with symp-
tomatic breast cancer31 but they did inﬂuence how
healthy women felt they would approach seeking help
should they develop cancer symptoms.22 Further,
although in some studies, the ﬁnancial burden of
healthcare16 26 33 and access issues16 33 did not inﬂuence
delay among those women with breast cancer, healthy
women cited both of these issues as potential barriers to
their future help-seeking.22 These differences highlight
that researchers may get different answers depending on
whether they ask healthy women or women with cancer
about delay/help-seeking intention.
DISCUSSION
Delayed presentation with breast cancer in black women
living in the USA and the UK appears to be inﬂuenced
by multiple factors and to be highly individual and
complex. Logically, all women may present late if they
have limited awareness of the disease and its symp-
toms.35 Although, a relatively small number of studies
comparing black and white women were included in the
review, black women appear more likely than white
women to have limited understanding of breast cancer
and its risk factors. This might be the case particularly
among (1) migrant women from countries where health
campaigns about the disease are scarce, (2) women with
limited command of the host nation’s language and/or
low literacy who are, therefore, not reached by the host
nation’s health messages and (3) women from commu-
nities where it is culturally unacceptable to discuss
cancer and who, as a result, do not gain understanding
of the disease through word of mouth.
This review, consistent with health behaviour
models,36 37 illustrates how women’s understanding of
risk factors and their perceived personal risk inﬂuence
their sensitivity to breast cancer symptoms and help-
seeking on identifying them. Black women rightly per-
ceive their risk of breast cancer to be lower than in
white women.2 3 Consequently, they may retain little
information provided to them by healthcare profes-
sionals or portrayed in breast cancer health promotion
campaigns, as they may believe it to be of limited per-
sonal relevance.
Findings from studies incorporated in this review
determined that many women lack conﬁdence in check-
ing, or are reluctant to check their breasts. However, if
women are unaware of how their breasts typically feel,
they will, as a consequence, face challenges in recognis-
ing subtle changes and may only detect change when
the disease is relatively advanced.
Clearly, early presentation with cancer is not solely
dependent on knowledge. Women with good knowledge
of the disease may not seek help from healthcare profes-
sionals on detecting symptoms of breast cancer.38 This
review suggests that fear may be an important factor pre-
venting black women from seeking help. It appears multi-
faceted—women referred to fear of cancer treatments
and abandonment by partners. Arguably, health mes-
sages communicating negative consequences of delayed
presentation with breast cancer may be less effective than
those framed in ways outlining beneﬁts of early presenta-
tion. Fear-led messages may lead to avoidance and denial
in people who fear a cancer diagnosis.36 Further,
although it appears that disclosure to others about symp-
toms indicative of breast cancer can be important in pro-
moting early presentation with the disease,39 it is not
uncommon for black women to feel uncomfortable
about disclosing symptoms to others, including health-
care professionals. This is due to the taboo and embar-
rassment associated with the disease.40 Women’s previous
encounters and rapport with healthcare professionals,
and any exposure to discrimination or misdiagnosis, also
appear to inﬂuence time to presentation.
Beliefs about the curability of breast cancer (a factor
impacting positively on early presentation) may be inﬂu-
enced in women born outside the country they live in by
experiences from their country of origin, where treat-
ments for cancer may be less effective and death more
likely.41 Religiosity might inﬂuence help-seeking behav-
iour but this will depend on how people perceive their
own role and that of a higher inﬂuence in managing
their health.42 The highly individual nature of religious
beliefs may explain why the inﬂuence of religiosity on
delay was unclear in this review. Further, it may reﬂect the
nature of the samples recruited to the reviewed studies.
Papers incorporated into the review did not unequivo-
cally support an association in the USA between ﬁnan-
cial barriers and late presentation with breast cancer in
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black and African-American women. It is likely that this
ﬁnding reﬂects sampling issues; black women sampled
in these studies appeared relatively afﬂuent, 58–92%
had health insurance. Work of others, including
Schneider, demonstrates clearly the coexistence of socio-
economic factors and ethnicity and their impact on
cancer staging and outcomes.43 However, it is important
to note that outside the USA, socioeconomic factors may
be more or less associated with ethnicity. They may also
impact differently on time to presentation with breast
cancer in differing healthcare systems.
Evidence from the sole UK study indicated that poor
knowledge of breast cancer and its associated symptoms,
and practical and ﬁnancial issues, may act as barriers to
early presentation with breast cancer in black African and
black Caribbean women. However, this study alone is
insufﬁcient to enable conclusions to be drawn on factors
impacting delayed diagnosis with breast cancer in black
women living in the UK. Further, it grouped all black
women together in the analysis. This would suggest that
black women are a homogenous group; it is very likely
that attitudes, help-seeking intention and help-seeking
behaviours will vary considerably within and between
black African and black Caribbean women in the UK and
possibly between ﬁrst-generation and second-generation
migrants. Merely labelling women as ‘black’ may mask
diverse attitudes and behaviours and lead researchers to
overlook important nuances.44 Further research is
needed in the UK to explore factors impacting early diag-
nosis with symptomatic breast cancer and to study in
detail the similarities and differences by ethnic group.
Unfortunately, while we aimed to compare in detail
barriers to early presentation with symptomatic breast
cancer between different groups of black women in the
USA and the UK, this proved impossible due to paucity of
UK studies and poor level of reporting in many of the
published US studies. Consequently, the speciﬁc nuances
between different ethnic groups of black women could
not be determined. However, it is striking that so many of
the beliefs, taboos and fears were similar among black
women, irrespective of their country of residence. These
factors are clearly not genetic which suggests cultural
factors are durable over many generations.
There was some evidence that some barriers to early
diagnosis had lessened during the period of this review.
This suggests that awareness-raising campaigns may have
been successful in raising the importance of early pres-
entation and overcoming practical challenges and per-
sonal concerns. Equally, the ﬁndings could reﬂect the
time that black women migrating to developed countries
had spent there. Arguably, migrants’ views will change
over time as they adapt to their surroundings and
become inﬂuenced by new cultures and health
systems.45 There was also some evidence of differences
between women with and without cancer, suggesting a
distinction between what women say they would do if
they discovered a symptom, versus what they do with the
onset of symptoms.
Further high-quality research is needed to better
understand barriers to early presentation and diagnosis
with breast cancer in black ethnic groups living outside
the USA. In particular, studies of, and comparisons
between, ethnic groups in the UK are needed to deter-
mine inﬂuences on delay in presentation and their pos-
sible contribution to the poorer survival of black African
and black Caribbean women in the UK.3 Researchers
need to compare stage at diagnosis and cancer survival
between ethnic groups after stratifying for tumour prog-
nostic and biological factors. This would allow the relative
inﬂuence of cancer biology, women’s delay and system
delay on outcomes to be determined. Findings of this
review have several implications for policy and practice.
Our review indicates that black women should feature
more prominently in media campaigns and educational
materials to prevent breast cancer being perceived as a
‘white women’s’ disease. Information about the risk of
breast cancer and its early symptoms, concerns about
breast checking, surgery and the side effects of treatment
also need to be addressed in ways that are culturally sensi-
tive to black women.46 47 Vulnerable women, who fear
partner abandonment and who may be reluctant to have
treatment for breast cancer as a result, need to be identi-
ﬁed and supported by healthcare professionals. Further,
enhancing women’s experiences of being diagnosed and
treated for breast cancer, and encouraging engagement
and discussion regarding the disease, may help to address
stigma and taboo, promote disclosure and allay women’s
fears, factors believed to impact positively on early pres-
entation and diagnosis.
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